Form 4: Pacira BioSciences Senior VP Sells Shares Following Restricted Stock Unit Vesting

Lauren Riker, Senior Vice President of Finance at Pacira BioSciences, Inc., reported the sale of common stock totaling 5,578.335 shares after a portion was withheld for tax obligations related to a restricted stock unit award.

Summary

• Lauren Riker, Senior Vice President, Finance of Pacira BioSciences, Inc. (PCRX), filed a Form 4 reporting changes in beneficial ownership of common stock.
• On June 3, 2025, 3,374 shares of common stock were withheld by the issuer at a price of $26.4 per share to cover tax withholding obligations upon the vesting of a restricted stock unit (RSU) award.
• Following this, on June 4, 2025, Ms. Riker sold 5,578.335 shares of common stock at a weighted average price of $26.21 per share. The sales occurred in multiple transactions at prices ranging from $26.15 to $26.38, inclusive.
• After these reported transactions, Ms. Riker beneficially owns 59,564 shares of Pacira BioSciences common stock.

Sentiment

Score: 5

Explanation: The document is a routine insider transaction report. While insider selling can be perceived negatively, the context of RSU vesting makes it a common occurrence, leading to a neutral sentiment.

Positives

• The vesting of restricted stock units indicates the fulfillment of equity compensation, which can be a positive for executive retention and motivation.

Negatives

• The sale of 5,578.335 shares by a Senior Vice President reduces direct insider ownership, which can sometimes be perceived as a slight negative signal regarding management's direct alignment with shareholder interests, although it is a common practice following RSU vesting.

Future Outlook

NA

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, which is a common occurrence following equity compensation vesting.
• Employees: The RSU vesting and subsequent transactions are part of the company's executive compensation structure.

Key Dates

Keywords

Pacira BioSciences, PCRX, SEC Form 4, Insider Trading, Stock Sale, Executive Compensation, Restricted Stock Units, Beneficial Ownership